Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 3
2006 1
2007 2
2008 1
2009 2
2010 2
2011 6
2012 6
2014 2
2015 6
2016 5
2017 3
2018 2
2019 2
2020 4
2021 1
2022 6
2023 4
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Letter to the editor.
Tsang RS, Jamieson FB, Lefebvre B, Gilca R. Tsang RS, et al. Among authors: gilca r. Can J Infect Dis Med Microbiol. 2014 Spring;25(1):8-38. doi: 10.1155/2014/847192. Can J Infect Dis Med Microbiol. 2014. PMID: 24634679 Free PMC article. No abstract available.
Repeat Influenza Vaccination and High-Dose Efficacy.
Skowronski DM, Chambers C, Gilca R, De Serres G. Skowronski DM, et al. Among authors: gilca r. Clin Infect Dis. 2016 Nov 1;63(9):1265-1266. doi: 10.1093/cid/ciw544. Epub 2016 Aug 9. Clin Infect Dis. 2016. PMID: 27506686 No abstract available.
Human metapneumovirus infections in hospitalized children.
Boivin G, De Serres G, Côté S, Gilca R, Abed Y, Rochette L, Bergeron MG, Déry P. Boivin G, et al. Among authors: gilca r. Emerg Infect Dis. 2003 Jun;9(6):634-40. doi: 10.3201/eid0906.030017. Emerg Infect Dis. 2003. PMID: 12781001 Free PMC article.
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada.
Skowronski DM, Febriani Y, Ouakki M, Setayeshgar S, El Adam S, Zou M, Talbot D, Prystajecky N, Tyson JR, Gilca R, Brousseau N, Deceuninck G, Galanis E, Fjell CD, Sbihi H, Fortin E, Barkati S, Sauvageau C, Naus M, Patrick DM, Henry B, Hoang LMN, De Wals P, Garenc C, Carignan A, Drolet M, Jassem AN, Sadarangani M, Brisson M, Krajden M, De Serres G. Skowronski DM, et al. Among authors: gilca r. Clin Infect Dis. 2022 Nov 30;75(11):1980-1992. doi: 10.1093/cid/ciac290. Clin Infect Dis. 2022. PMID: 35438175 Free PMC article.
Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada.
Carazo S, Talbot D, Boulianne N, Brisson M, Gilca R, Deceuninck G, Brousseau N, Drolet M, Ouakki M, Sauvageau C, Barkati S, Fortin É, Carignan A, De Wals P, Skowronski DM, De Serres G. Carazo S, et al. Among authors: gilca r. Clin Infect Dis. 2022 Aug 24;75(1):e805-e813. doi: 10.1093/cid/ciab739. Clin Infect Dis. 2022. PMID: 34460902 Free PMC article.
Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, Canada.
Carazo S, Skowronski DM, Brisson M, Sauvageau C, Brousseau N, Fafard J, Gilca R, Talbot D, Ouakki M, Febriani Y, Deceuninck G, De Wals P, De Serres G. Carazo S, et al. Among authors: gilca r. Lancet Healthy Longev. 2023 Aug;4(8):e409-e420. doi: 10.1016/S2666-7568(23)00099-5. Epub 2023 Jul 14. Lancet Healthy Longev. 2023. PMID: 37459879 Free article.
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study.
Carazo S, Skowronski DM, Brisson M, Barkati S, Sauvageau C, Brousseau N, Gilca R, Fafard J, Talbot D, Ouakki M, Gilca V, Carignan A, Deceuninck G, De Wals P, De Serres G. Carazo S, et al. Among authors: gilca r. Lancet Infect Dis. 2023 Jan;23(1):45-55. doi: 10.1016/S1473-3099(22)00578-3. Epub 2022 Sep 21. Lancet Infect Dis. 2023. PMID: 36152671 Free PMC article.
60 results